Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Controlled Release

• Publication date

  2000-08-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-3659(00)00267-4PMID 10925134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.

  2000cited by this paper
• Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study

  1999cited by this paper
• Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.

  1999cited by this paper
• Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.

  1998cited by this paper
• Ganciclovir implant exchange. Timing, surgical procedure, and complications.

  1997cited by this paper
• Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.

  1997cited by this paper
• Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materials

  1996cited by this paper
• Kinetics of diffusion-mediated drug release enhanced by matrix degradation

  1995cited by this paper
• Replacing ganciclovir implants.

  1995cited by this paper
• Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits

  1995cited by this paper
• The influence of biodegradable microcapsule formulations on the controlled release of a protein

  1994cited by this paper
• Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

  1994cited by this paper
• Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients

  1992cited by this paper
• Treatment of cytomegalovirus retinitis--1992.

  1992cited by this paper
• Intravitreal sustained-release ganciclovir.

  1992cited by this paper
• Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome.

  1991cited by this paper
• Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome.

  1990cited by this paper
• Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media

  1990cited by this paper
• Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media

  1990cited by this paper
• Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media

  1990cited by this paper
• The acceleration of degradation-controlled drug delivery from polyester microspheres

  1989cited by this paper
• Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results.

  1989cited by this paper
• Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

  1989cited by this paper
• Cytomegalovirus retinitis.

  1989cited by this paper
• The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems

  1989cited by this paper
• Cytomegalovirus retinitis and response to therapy with ganciclovir.

  1987cited by this paper
• Treatment of cytomegalovirus retinitis with ganciclovir.

  1987cited by this paper
• Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

  1987cited by this paper
• Treatment of Cytomegalovirus Retinopathy in Patients With Acquired Immunodeficiency Syndrome: Use of the Experimental Drug 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

  1986cited by this paper
• Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament

  1986cited by this paper
• Control of release rate of bleomycin from polylactic acid microspheres by additives.

  1985cited by this paper
• Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

  1985cited by this paper
• Ophthalmic involvement in acquired immunodeficiency syndrome.

  1984cited by this paper
• Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

  1984cited by this paper
• 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent.

  1983cited by this paper
• Acquired immune deficiency syndrome. Ocular manifestations.

  1983cited by this paper
• Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

  1983cited by this paper
• Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo.

  1981cited by this paper
• Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers

  1979cited by this paper
• Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers.

  1979cited by this paper
• Rate of release of medicaments from ointment bases containing drugs in suspension.

  1961cited by this paper

• Long-Term Follow-up of Patients With Cytomegalovirus Retinitis Treated With a Ganciclovir Implant

  2024influential citation
• Targeting Posterior Eye Infections with Colloidal Carriers: The Case of Ganciclovir.

  2023cites this paper
• Promising Role of Silk-Based Biomaterials for Ocular-Based Drug Delivery and Tissue Engineering

  2022cites this paper
• Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous

  2021cites this paper
• Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment.

  2021cites this paper
• Rosmarinic Acid Intravitreal Implants: A New Therapeutic Approach for Ocular Neovascularization

  2020cites this paper
• Amorphous binary dispersions of chloramphenicol in enantiomeric pure and racemic poly-lactic acid: morphology, molecular relaxations, and controlled drug release.

  2019cites this paper
• Antileishmanial and Immunomodulatory Effect of Babassu-Loaded PLGA Microparticles: A Useful Drug Target to Leishmania amazonensis Infection

  2018cites this paper
• Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l‐lactide‐co‐glycolide) or polycaprolactone

  2018cites this paper
• Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.

  2018cites this paper
• Long-term delivery of rhIGF-1 from biodegradable poly(lactic acid)/hydroxyapatite@Eudragit double-layer microspheres for prevention of bone loss and articular degeneration in C57BL/6 mice.

  2018cites this paper
• Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats.

  2017cites this paper
• Controlled basic fibroblast growth factor release device made of poly(ethyleneglycol) dimethacrylates for creating a subcutaneous neovascular bed for cell transplantation.

  2017cites this paper
• 3D Printed Drug Delivery System for Epilepsy

  2016influential citation
• Biomaterials for intraocular sustained drug delivery

  2016cites this paper
• Liposomal Drug Delivery: Light Triggered Drug Release and Targeting to the Posterior Segment of the Eye

  2016cites this paper
• Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis

  2015cites this paper
• A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye.

  2014cites this paper
• Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.

  2014cites this paper
• A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles.

  2014cites this paper
• Nanostructure-based platforms-current prospective in ophthalmic drug delivery

  2014cites this paper
• A Platform for Controlled Dual‐Drug Delivery to the Retina: Protective Effects against Light‐Induced Retinal Damage in Rats

  2014cites this paper
• Titanium pyridonates and amidates: novel catalysts for the synthesis of random copolymers.

  2013cites this paper
• PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.

  2013cites this paper
• Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization

  2013cites this paper
• Critical Assessment of Implantable Drug Delivery Devices in Glaucoma Management

  2013cites this paper
• PLA/PEG-PPG-PEG/Dexamethasone implant prepared by hot-melt extrusion for controlled release of immunosuppressive drug to implantable medical devices, part 2: in vivo evaluation

  2013cites this paper
• Hierarchical Structure of Electrospun Composite Fibers for Long‐Term Controlled Drug Release Carriers

  2012cites this paper
• Intravitreal Devices for the Treatment of Vitreous Inflammation

  2012cites this paper
• Contact lenses in ocular therapeutics.

  2012cites this paper
• Pulsatile drug release from PLGA hollow microspheres by controlling the permeability of their walls with a magnetic field.

  2012cites this paper
• Anti-bacterial and Anti-adhesive Nanostructured Coatings for Improved Implant Biocompatibility

  2012cites this paper
• A Novel Shear Thinning and Thixotropic Plga Micro Particulate Suspension System for Controlled Drug Delivery

  2011cites this paper
• Toxicity of a Biodegradable Microneedle Implant Loaded with Methotrexate as a Sustained Release Device in Normal Rabbit Eye: A Pilot Study

  2011cites this paper
• A “tool box” for rational design of degradable controlled release formulations

  2011cites this paper
• Ácido Poliláctico (PLA): Propiedades y Aplicaciones

  2011cites this paper
• Biodegradable implants with different drug release profiles

  2011influential citation
• Electrochemical studies of ganciclovir at boron-doped nanocrystalline diamond electrodes

  2011cites this paper
• A scalable controlled-release device for transscleral drug delivery to the retina.

  2011cites this paper
• Delivery of anti-angiogenic molecular therapies for retinal disease.

  2010cites this paper
• Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid.

  2010cites this paper
• Medical devices for the treatment of eye diseases.

  2010cites this paper
• Biodegradable Intraocular Therapies for Retinal Disorders

  2010cites this paper
• INTRAVITREAL IMPLANT USING BIODEGRADABLE PLGA

  2010cites this paper
• Investigation of Kinetics of Methotrexate for Therapeutic Treatment of Intraocular Lymphoma

  2010cites this paper
• Safety and Efficacy of Nano/Micro Materials

  2009cites this paper
• Poly-epsilon-caprolactone intravitreous devices: an in vivo study.

  2009cites this paper
• Controlled release of dexamethasone acetate from biodegradable and biocompatible polyurethane and polyurethane nanocomposite

  2009cites this paper
• Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.

  2009cites this paper
• Recent Perspectives in Ocular Drug Delivery

  2009cites this paper
• Development and validation of HPLC method for quantitative analysis of triamcinolone in biodegradable microparticles

  2009cites this paper
• A biodegradable drug delivery system for the treatment of postoperative inflammation.

  2008cites this paper
• Studies on Indomethacin Intraocular Implants Using Different in vitro Release Methods

  2008cites this paper
• Particle Characteristics and Biodistribution of Camptothecin-Loaded PLA/(PEG-PPG-PEG) Nanoparticles

  2008cites this paper
• MICROPARTÍCULAS BIODEGRADÁVEIS PARA LIBERAÇÃO PROLONGADA INTRAOCULAR DE CETOROLACO DE TROMETAMINA OBTIDAS POR "SPRAY DRYING"

  2008cites this paper
• Ocular Implants For Drug Delivery

  2008cites this paper
• Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.

  2008cites this paper
• Thermal analysis of biodegradable microparticles containing ciprofloxacin hydrochloride obtained by spray drying technique

  2008cites this paper
• Dexamethasone-loaded poly(ε-caprolactone) intravitreal implants: A pilot study

  2008cites this paper
• Chapter 4 Safety and Efficacy of Nano / Micro Materials

  2008cites this paper
• Fabrication of a biodegradable drug delivery system with controlled release made of PLGA/5‐FU/hydroxyapatite

  2008cites this paper
• Intraocular Implants for Controlled Drug Delivery

  2008cites this paper
• Development of drug-delivery systems to the posterior segments of the eye

  2007cites this paper
• ABRICATION OF BIODEGRADABLE DRUG DELIVERY SYSTEM USING NANO COMPOSITE DEPOSITION SYSTEM

  2007cites this paper
• Dispositifs de délivrance de principes actifs pour des applications ophtalmologiques

  2007cites this paper
• Fabrication of Bio-Composite Drug Delivery System Using Rapid Prototyping Technology

  2007cites this paper
• [Drug delivery systems for intraocular applications].

  2007cites this paper
• Novel approaches to retinal drug delivery

  2007cites this paper
• Sustained-Release Ophthalmic Drug Delivery Systems for Treatment of Macular Disorders

  2007cites this paper
• Controlled Delivery of Ganciclovir to the Retina with Drug-Loaded Poly(D,L-lactide-co-glycolide) (PLGA) Microspheres Dispersed in PLGA-PEG-PLGA Gel: A Novel Intravitreal Delivery System for the Treatment of Cytomegalovirus Retinitis

  2007cites this paper
• Novel Drug Delivery Systems for Posterior Segment Ocular Disease

  2006cites this paper
• Ocular Barriers to Transscleral Drug Delivery and Pharmacokinetics of an Episcleral Implant

  2006cites this paper
• Safety and Pharmacokinetics of an Intravitreal Biodegradable Implant of Dexamethasone Acetate in Rabbit Eyes

  2006cites this paper
• Intraocular implants for extended drug delivery: therapeutic applications.

  2006cites this paper
• A mathematical model for interpreting in vitro rhGH release from laminar implants.

  2006cites this paper
• Drug delivery from ocular implants

  2006cites this paper
• PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases.

  2005cites this paper
• Colloidal carriers for ophthalmic drug delivery.

  2005cites this paper
• Intraocular sustained drug delivery using implantable polymeric devices.

  2005cites this paper
• Manufacturing Techniques of Biodegradable Implants Intended for Intraocular Application

  2005cites this paper
• Vectorisation intra-oculaire

  2004cites this paper
• Drug delivery systems for vitreoretinal diseases.

  2004cites this paper
• Development of implant tablet for a week-long sustained release.

  2004cites this paper
• Novel approaches to ocular drug delivery.

  2004cites this paper
• [Drug delivery to target the posterior segment of the eye].

  2004cites this paper
• Interfacial adhesion in model bioblends

  2004cites this paper
• Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.

  2003cites this paper
• Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.

  2003cites this paper
• Strontium‐based initiator system for ring‐opening polymerization of cyclic esters

  2003cites this paper
• Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.

  2003cites this paper
• Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits

  2002cites this paper
• Self-reinforced polylactic acid implant fixation for arthrodeses in rheumatoid arthritis and ankle fractures - a short- and long-term study

  2002cites this paper
• Model compound release from DL‐lactide/ε‐caprolactone copolymers and evaluation of specific interactions by molecular modeling

  2002cites this paper
• Potential applications of PLGA film-implants in modulating in vitro drugs release.

  2002cites this paper
• Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.

  2001cites this paper
• Biodegradable Polymers for Ocular Drug Delivery

  2001influential citation
• Nanostructure Science and Technology

  1999cites this paper